Barclays’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.3M Buy
383,179
+247,131
+182% +$25M 0.01% 838
2025
Q4
$10.8M Sell
136,048
-154,401
-53% -$10.1M ﹤0.01% 1627
2025
Q3
$13.6M Buy
290,449
+34,065
+13% +$1.33M 0.01% 1455
2025
Q2
$9.43M Sell
256,384
-22,067
-8% -$848K ﹤0.01% 1631
2025
Q1
$9.85M Sell
278,451
-130,163
-32% -$5.28M ﹤0.01% 1419
2024
Q4
$17.9M Buy
408,614
+113,950
+39% +$5.75M 0.01% 1196
2024
Q3
$13.4M Buy
294,664
+192,021
+187% +$8.36M 0.01% 1289
2024
Q2
$3.98M Sell
102,643
-32,773
-24% -$1.22M ﹤0.01% 1677
2024
Q1
$4.36M Sell
135,416
-218,369
-62% -$6.47M ﹤0.01% 1959
2023
Q4
$10.1M Buy
353,785
+125,124
+55% +$3.01M 0.01% 1504
2023
Q3
$6.33M Buy
228,661
+42,336
+23% +$1.26M ﹤0.01% 1193
2023
Q2
$4.98M Buy
186,325
+38,376
+26% +$942K ﹤0.01% 1350
2023
Q1
$3.2M Buy
147,949
+5,950
+4% +$147K ﹤0.01% 1847
2022
Q4
$3.38M Sell
141,999
-27,918
-16% -$594K ﹤0.01% 1895
2022
Q3
$3.35M Buy
169,917
+139,256
+454% +$3.06M ﹤0.01% 1405
2022
Q2
$598K Sell
30,661
-7,052
-19% -$137K ﹤0.01% 2744
2022
Q1
$962K Buy
+37,713
New +$821K ﹤0.01% 2441

Other funds holding RVMD